KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Capital Expenditures (2016 - 2025)

Colgate Palmolive has reported Capital Expenditures over the past 17 years, most recently at $177.0 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $177.0 million for Q4 2025, down 3.8% from a year ago — trailing twelve months through Dec 2025 was $564.0 million (up 0.53% YoY), and the annual figure for FY2025 was $564.0 million, up 0.53%.
  • Capital Expenditures for Q4 2025 was $177.0 million at Colgate Palmolive, up from $155.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for CL hit a ceiling of $221.0 million in Q4 2022 and a floor of $107.0 million in Q1 2021.
  • Median Capital Expenditures over the past 5 years was $158.0 million (2023), compared with a mean of $154.6 million.
  • Biggest five-year swings in Capital Expenditures: soared 68.83% in 2021 and later tumbled 36.41% in 2024.
  • Colgate Palmolive's Capital Expenditures stood at $193.0 million in 2021, then rose by 14.51% to $221.0 million in 2022, then decreased by 10.86% to $197.0 million in 2023, then fell by 6.6% to $184.0 million in 2024, then decreased by 3.8% to $177.0 million in 2025.
  • The last three reported values for Capital Expenditures were $177.0 million (Q4 2025), $155.0 million (Q3 2025), and $108.0 million (Q2 2025) per Business Quant data.